Evidence map›Paper›PMID 39827310›Full record

SynthesisGeroScience2025

Enhancing cognitive functions in aged dogs and cats: a systematic review of enriched diets and nutraceuticals.

Tiphaine Blanchard, Justine Eppe, Amélie Mugnier, Fabienne Delfour, Annabelle Meynadier

Abstract readSystematic Review
In one paragraph

Synthesis in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tiphaine BlanchardGenPhySE, Université de Toulouse, INRAE, ENVT, 31326, Castanet Tolosan, France. tiphaine.blanchard@envt.fr.ORCID 0000-0003-3009-651X
Justine EppeClinical Department of Production Animals, Fundamental and Applied Research for Animals & Health Research Unit (FARAH), Faculty of Veterinary Medicine, University of Liège, Liege, Belgium.
Amélie MugnierLallemand SAS, 31700, Blagnac, France.
Fabienne DelfourILCB- Aix Marseille Université, 13284, Marseille, France.
Annabelle MeynadierGenPhySE, Université de Toulouse, INRAE, ENVT, 31326, Castanet Tolosan, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With advancements in veterinary care and the growing recognition of pets as integral member of the family, the lifespans of dogs and cats have significantly increased, leading to a higher prevalence of age-related conditions, including cognitive dysfunction syndrome (CDS). CDS adversely impacts pets' quality of life and presents emotional and practical challenges for owners. Given its similarities to Alzheimer's disease in humans, CDS has gained attention as a target for nutrition-based interventions aimed at preserving cognitive function. This systematic review evaluates the efficacy of enriched diets and nutraceuticals in improving cognition in aging companion animals. A literature search was conducted using PubMed, CAB Abstracts, Web of Science, and Dimensions to identify clinical trials published in English that investigated the effects of enriched diets or nutraceuticals on cognitive functions in aged cats or dogs. Study quality was assessed using a modified CAMARADES checklist. A total of 30 studies (27 canine and 2 feline trials) published between 2002 and 2023 were reviewed. Studies on enriched diets generally demonstrated higher methodological quality compared to those on supplements. Omega-3 fatty acids showed cognitive benefits in aging pets, especially at higher doses, while antioxidants from plant extracts and products and vitamins E and C alone were less effective but remain essential for stabilizing omega-3 fatty acids. Other supplements, including S-adenosyl methionine, medium-chain triglycerides, homotaurine, and apoaequorin, also showed promise. However, future studies must standardize protocols, include robust control groups, and utilize both objective tasks and subjective questionnaires to strengthen conclusions.

Indexed as

AgingCognitionCognitive DysfunctionDietDietary SupplementsAnimalsCatsDogsFatty Acids, Omega-3Fatty Acids, Omega-3AgingCanineCognitionFelineFood additivesNutrition therapy

Identifiers

PMID39827310
PMCPMC12181554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.